Levy Richard S's Form 4/A amendment
AmendedProtara Therapeutics, Inc. (TARA) · filed May 19, 2025
- Accession no.
- 0001213900-25-045399
- Filed
- May 19, 2025
- Trade date
- May 14, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 16, 2025
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $63.8K. It was filed 5 days after the trade.
This amendment replaces 0001213900-25-044871 (filed May 16, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levy Richard SCIK 0001454983 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Common Stock | PPurchaseAcquired | +20,000 | $3.19 | +$63,800 | 51,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.